India's Dr Reddy's tops Q2 profit view on higher sales

Explore stories from Atlantic Canada.

SaltWire's Atlantic regional weather forecast for October 26, 2023 | SaltWireHyderabad/Bengaluru - India's Dr Reddy's Laboratories reported a bigger-than-expected rise in second-quarter profit on Friday, boosted by strong U.S. sales of its generic version of the popular cancer drug Revlimid.

The company's consolidated net profit after tax rose 33% to 14.82 billion rupees in the quarter ended Sept. 30, beating analysts' average estimate of 12.69 billion rupees, as per LSEG data.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

ATLANTIC ECONOMIC COUNCIL: Another challenging year for Atlantic Canada’s economy in 2024Explore stories from Atlantic Canada.
Read more »

Conservatives challenging Nasdaq board diversity rule appeal to full 5th CircuitExplore stories from Atlantic Canada.
Read more »

The Bomadils nominated for three Canadian Folk Music AwardsExplore stories from Atlantic Canada.
Read more »

Cobequid Wildlife Rehab Centre helping injured critters return homeExplore stories from Atlantic Canada.
Read more »

July cyber-attack continues to delay tax bills for Kings County, N.S., property ownersExplore stories from Atlantic Canada.
Read more »

Amherst man, 22, man facing charges after Springhill stabbing that sent victim to Halifax hospitalExplore stories from Atlantic Canada.
Read more »